|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM147450780 |
003 |
DE-627 |
005 |
20231223043357.0 |
007 |
tu |
008 |
231223s2004 xx ||||| 00| ||eng c |
028 |
5 |
2 |
|a pubmed24n0492.xml
|
035 |
|
|
|a (DE-627)NLM147450780
|
035 |
|
|
|a (NLM)15047201
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Mallone, Roberto
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a MHC Class II tetramers and the pursuit of antigen-specific T cells
|b define, deviate, delete
|
264 |
|
1 |
|c 2004
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
500 |
|
|
|a Date Completed 12.05.2004
|
500 |
|
|
|a Date Revised 14.11.2007
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Selective expansion and activation of a very small number of antigen-specific CD4(+) T cells is a remarkable and essential property of the adaptive immune response. Antigen-specific T cells were until recently identified only indirectly by functional assays, such as antigen-induced cytokine secretion and proliferation. The advent of MHC Class II tetramers has added a pivotal tool to our research armamentarium, allowing the definition of allo- and autoimmune responses in deeper detail. Rare antigen-specific CD4(+) cells can now be selectively identified, isolated and characterized. The same tetramer reagents also provide a new mean of stimulating T cells, more closely reproducing the MHC-peptide/TCR interaction. This property allows the use of tetramers to direct T cells toward the more desirable outcome, that is, activation (in malignancies and infectious diseases) or Th2/T regulatory cell deviation, anergy and deletion (in autoimmune diseases). These experimental approaches hold promise for diagnostic, prognostic and therapeutic applications
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, U.S. Gov't, P.H.S.
|
650 |
|
4 |
|a Review
|
650 |
|
7 |
|a Antigens
|2 NLM
|
650 |
|
7 |
|a Epitopes, T-Lymphocyte
|2 NLM
|
650 |
|
7 |
|a Histocompatibility Antigens Class II
|2 NLM
|
650 |
|
7 |
|a Receptors, Antigen, T-Cell
|2 NLM
|
700 |
1 |
|
|a Nepom, Gerald T
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 110(2004), 3 vom: 15. März, Seite 232-42
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:110
|g year:2004
|g number:3
|g day:15
|g month:03
|g pages:232-42
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 110
|j 2004
|e 3
|b 15
|c 03
|h 232-42
|